Best TWAS P=1.72e-28 · Best GWAS P=3.73e-30 conditioned to NaN
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | GTEx | Artery Tibial | CLCN6 | 0.14 | 0.04 | lasso | 6 | 0.04 | 5.0e-04 | -7.107 | -5.5 | 3.0e-08 | -0.06 | 0.10 | 0.89 | FALSE |
2 | GTEx | Breast Mammary Tissue | NPPA-AS1 | 0.25 | 0.01 | lasso | 4 | 0.02 | 3.0e-02 | 4.189 | 5.2 | 1.6e-07 | 0.08 | 0.46 | 0.05 | TRUE |
3 | GTEx | Breast Mammary Tissue (Female) | NPPA-AS1 | 0.16 | 0.01 | lasso | 3 | 0.00 | 3.4e-01 | 4.189 | 5.2 | 1.7e-07 | 0.08 | 0.07 | 0.11 | FALSE |
4 | GTEx | Cells EBV-transformed lymphocytes | MTHFR | 0.33 | 0.12 | lasso | 6 | 0.09 | 7.9e-04 | -6.905 | -6.9 | 5.0e-12 | -0.07 | 0.33 | 0.29 | FALSE |
5 | GTEx | Cells Transformed fibroblasts | CLCN6 | 0.08 | 0.02 | enet | 17 | 0.05 | 1.6e-04 | -11.051 | -8.6 | 5.5e-18 | -0.12 | 0.01 | 0.99 | FALSE |
6 | GTEx | Cells Transformed fibroblasts | MTHFR | 0.13 | 0.03 | enet | 30 | 0.05 | 6.8e-05 | -8.014 | -8.3 | 6.6e-17 | -0.05 | 0.04 | 0.93 | TRUE |
7 | GTEx | Skin Not Sun Exposed Suprapubic | CLCN6 | 0.12 | 0.03 | lasso | 3 | 0.04 | 3.3e-03 | -5.714 | -9.1 | 1.0e-19 | -0.05 | 0.02 | 0.94 | FALSE |
8 | GTEx | Skin Sun Exposed Lower leg | CLCN6 | 0.08 | 0.00 | lasso | 3 | 0.01 | 7.9e-02 | -4.389 | -6.9 | 4.4e-12 | -0.08 | 0.03 | 0.72 | FALSE |
9 | GTEx | Spleen | CLCN6 | 0.21 | 0.10 | lasso | 3 | 0.06 | 1.3e-02 | -6.914 | -8.2 | 2.8e-16 | -0.07 | 0.04 | 0.72 | TRUE |
10 | GTEx | Stomach | RP4-635E18.7 | 0.13 | 0.06 | enet | 25 | 0.03 | 8.8e-03 | -1.163 | -5.3 | 1.0e-07 | -0.44 | 0.12 | 0.58 | TRUE |
11 | GTEx | Testis | NPPA | 0.36 | 0.23 | lasso | 9 | 0.24 | 5.0e-11 | -3.467 | 5.4 | 7.3e-08 | 0.05 | 1.00 | 0.00 | FALSE |
12 | METSIM | Adipose | CLCN6 | 0.09 | 0.04 | blup | 480 | 0.06 | 1.6e-09 | -6.244 | -7.6 | 2.7e-14 | -0.10 | 0.06 | 0.94 | FALSE |
13 | METSIM | Adipose | DRAXIN | 0.09 | 0.01 | enet | 21 | 0.04 | 1.6e-06 | -0.079 | 5.6 | 2.5e-08 | -0.05 | 0.03 | 0.92 | FALSE |
14 | NTR | Blood | AGTRAP | 0.02 | 0.00 | bslmm | 484 | 0.00 | 5.2e-02 | 0.578 | 6.2 | 7.4e-10 | 0.08 | 0.05 | 0.06 | FALSE |
15 | NTR | Blood | CLCN6 | 0.01 | 0.01 | lasso | 2 | 0.01 | 3.0e-04 | -7.107 | -5.8 | 8.0e-09 | -0.05 | 0.38 | 0.54 | FALSE |
16 | NTR | Blood | MTHFR | 0.09 | 0.07 | enet | 17 | 0.10 | 4.4e-31 | -4.210 | -7.4 | 1.3e-13 | -0.07 | 1.00 | 0.00 | TRUE |
17 | ROSMAP | Brain Pre-frontal Cortex | C1orf167 | 0.07 | 0.01 | blup | 475 | 0.03 | 1.4e-04 | -6.350 | -5.9 | 3.4e-09 | -0.03 | 0.36 | 0.04 | FALSE |
18 | ROSMAP | Brain Pre-frontal Cortex | NPPA-AS1 | 0.38 | 0.41 | lasso | 12 | 0.50 | 4.6e-73 | -3.458 | 5.6 | 2.5e-08 | 0.06 | 1.00 | 0.00 | TRUE |
19 | YFS | Blood | MTHFR | 0.50 | 0.49 | enet | 40 | 0.62 | 5.5e-264 | -4.210 | -6.0 | 2.7e-09 | -0.06 | 1.00 | 0.00 | FALSE |
20 | The Cancer Genome Atlas | Breast Invasive Carcinoma | CLCN6 | 0.06 | 0.06 | blup | 104 | 0.06 | 5.0e-12 | -8.198 | -11.1 | 1.7e-28 | -0.09 | 0.22 | 0.78 | TRUE |
21 | The Cancer Genome Atlas | Colon Adenocarcinoma | CLCN6 | 0.14 | 0.05 | blup | 104 | 0.09 | 1.2e-05 | -10.766 | -7.7 | 1.2e-14 | -0.04 | 0.01 | 0.98 | FALSE |
22 | The Cancer Genome Atlas | Colon Adenocarcinoma | MTHFR | 0.07 | 0.01 | blup | 92 | 0.04 | 2.9e-03 | -0.572 | -7.1 | 1.2e-12 | -0.07 | 0.04 | 0.47 | FALSE |
23 | The Cancer Genome Atlas | Colon Adenocarcinoma | NPPA | 0.06 | 0.01 | lasso | 5 | 0.01 | 1.3e-01 | -3.710 | 6.2 | 6.9e-10 | 0.06 | 0.04 | 0.24 | FALSE |
24 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | CLCN6 | 0.04 | 0.06 | lasso | 2 | 0.05 | 1.1e-06 | -8.198 | -9.2 | 2.2e-20 | -0.08 | 0.10 | 0.89 | FALSE |
25 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | CLCN6 | 0.05 | 0.05 | lasso | 6 | 0.05 | 9.2e-07 | -4.389 | -7.3 | 2.5e-13 | -0.07 | 0.50 | 0.47 | FALSE |
26 | The Cancer Genome Atlas | Kidney Renal Papillary Cell Carcinoma | CLCN6 | 0.07 | 0.00 | blup | 104 | 0.03 | 7.9e-03 | 3.698 | -7.4 | 1.2e-13 | -0.09 | 0.06 | 0.28 | FALSE |
27 | The Cancer Genome Atlas | Lung Adenocarcinoma | CLCN6 | 0.06 | 0.04 | blup | 104 | 0.04 | 5.2e-06 | -11.051 | -10.7 | 8.9e-27 | -0.07 | 0.01 | 0.99 | TRUE |
28 | The Cancer Genome Atlas | Prostate Adenocarcinoma | CLCN6 | 0.10 | 0.07 | blup | 104 | 0.07 | 3.9e-08 | -8.228 | -10.3 | 4.5e-25 | -0.06 | 0.20 | 0.80 | FALSE |
29 | The Cancer Genome Atlas | Stomach Adenocarcinoma | CLCN6 | 0.07 | 0.04 | blup | 104 | 0.05 | 2.4e-04 | -10.766 | -10.0 | 1.2e-23 | -0.09 | 0.01 | 0.98 | FALSE |
30 | The Cancer Genome Atlas | Stomach Adenocarcinoma | NPPA | 0.06 | 0.03 | enet | 4 | 0.04 | 7.6e-04 | -8.228 | 6.8 | 9.9e-12 | 0.05 | 0.11 | 0.15 | TRUE |
31 | The Cancer Genome Atlas | Thyroid Carcinoma | CLCN6 | 0.08 | 0.02 | blup | 104 | 0.05 | 2.5e-05 | -6.350 | -8.2 | 1.6e-16 | -0.06 | 0.15 | 0.84 | FALSE |